Trademark Information

Application ID
Status
Date of Application
16 January 2021
Classes
5
Proprietor
Johnson Johnson
One Johnson & Johnson Plaza, New Brunswick, New Jersey 08933, United States Of America
Attorney
Lall & Sethi[23687]
D 17, South Extension Part Ii, New Delhi 110049, India
Type
Word
State
State Not Specified
Country
Filing Mode
e-Filing
IP Office
DELHI
Used Since
Valid / Upto
16 January 2031
Description
[Class : 5] Human Pharmaceuticals For The Treatment Of Cancer, Excluding Human Pharmaceuticals For The Treatment Of Autoimmune Conditions, Rheumatoid Arthritis, And Multiple Sclerosis.

Documents

Examination Report

Uploaded Documents

1 TM-A(CONVENTION APPLICATION) 16 Jan 2021
2 Priority Document 16 Mar 2021
3 Reply to Exam Report (MIS-R) 19 Mar 2021
4 Journal Copy 04 May 2021
5 TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) 27 Jul 2021
6 Certificate 12 Oct 2021

Frequently Asked Questions

When was the trademark applied?

The application for Istrelzo was made on 16 January 2021.

Who is the applicant for Istrelzo?

The trademark applicant for Istrelzo is JOHNSON JOHNSON.

In what class is the trademark applied to?

Istrelzo is applied in class(es) 5.

What is the status of the trademark application?

Application for Istrelzo is on Registered stage.

What is the application ID of the trademark?

Application Id allotted to Istrelzo is 4823196.

Who is the trademark agent or attorney?

Trademark agent or attorney for the application is Lall & Sethi.

What is the type of trademark application?

Istrelzo filed with the Intellectual property office as a WORD.

Login SignUp